What is the main material of the guidewire?

The guidewire is made from Nitinol with a hydrophilic coating.

Where are your products shipped from?

We ship from Shenzhen Port, Hong Kong Port, and Guang Zhou Port.

Microapproach Nitinol Hydrophilic Guidewire with CE Mdr

Name: Microapproach Nitinol Hydrophilic Guidewire with CE Mdr
Brand: Shenzhen Microapproach Medical Technology Co., Ltd.
SKU: 1937319265

Guangdong, ChinaShenzhen Microapproach Medical Technology Co., Ltd.

US$5.00-20.00

500 Pieces

Sample price:US$0.10/piece.Request sample

Product profile

Customization

Available

Sterilization

Feature

Disposable

Model NO.

GWO-35-180S

Application

Clinical

Material

Nitinol

Certification

CE, ISO13485, FSC

Power Type

Without Power

Group

Adult

Option

OEM/ODM

Transport Package

Paper-Poly Pouch+ Carton

Specification

0.035", 180cm

Trademark

Rapidguid

Origin

China

Key features

Advanced Hydrophilic Coating: Provides lasting lubrication for smooth navigation.

Soft Atraumatic Tip: Ensures flexibility and minimizes tissue trauma.

Nitinol Core Construction: Delivers 1:1 torque control and perfect maneuverability.

Enhanced Visualization: Allows for accurate positioning during procedures.

Complete Specification Range: Accommodates diverse physician preferences.

CE and ISO13485 Certified: Meets international medical device safety standards.

OEM and ODM Services: Customization options available for branding and design.

Disposable Design: Single-use product for enhanced clinical safety.

Company profile

Shenzhen Microapproach Medical Technology Co., Ltd.

Guangdong, China

CertifiedBusiness Type: Manufacturer/Factory & Trading Company CertifiedR&D Capacity: ODM Service Available & OEM Service AvailableExport Year: 2015-09-02 CertifiedNearest Port: Shenzhen Port, Hong Kong Port, Guang Zhou PortAverage Response Time: ≤9.61h CertifiedTerms of Payment: LC, T/T, PayPal, etc.

AI-Powered supplier vetting

SummaryMicroApproach Medical is presented as a Shenzhen-based high-tech manufacturer focused on interventional medical products, including guidewires, catheters, introducer sheaths, and related equipment. The available information indicates established R&D activities, including a Japan R&D center, a stated medical-device quality management system, more than 10 production lines, and annual guidewire output of 4,000,000 pieces. Its export activity began in 2015, with exports representing 31%–40% of total sales. The supplier has documented transactions involving guidewires, introducer sheath kits, and Y connector sets with a Vietnam-based buyer, but the evidence does not establish the breadth of its after-sales service, customization process, formal certification portfolio, or overall customer base.

Supplier typeThe supplier is explicitly described as a national high-tech enterprise engaged in the R&D, production, and sales of interventional medical products. Its listed products include guidewires, catheters, introducer sheaths, interventional instruments, and related manufacturing equipment, indicating a specialized medical-device manufacturer rather than a general trading company.

R&D capabilityThe company states that it has strong R&D capability across polymer materials, biomedical engineering, and clinical medicine, maintains an R&D center in Japan, and continuously develops new products based on clinical requirements. These are explicit indicators of an established innovation orientation and technical development capability.

Production capacityThe supplier reports a 5,873.57 m² manufacturing plant, more than 10 production lines, 6–10 quality-control staff, and annual guidewire output of 4,000,000 pieces. It also states that it has established a high-quality production line for medical-device solutions, providing direct evidence of substantial production capability.

Client casesThe available trade records identify a Vietnam destination and one named buyer, CÔNG TY TNHH Y TẾ KHANG KHẢI, with transactions involving introducer sheath kits, a Y connector set, and a guidewire. These records provide evidence of at least one documented customer relationship and product shipments, but do not demonstrate a broad or independently verified customer portfolio.